Researchers reversed the biological age of skin cells by 30 years without changing their identity. Here is what that actually means for skin care.

In brief: Scientists at the Babraham Institute in Cambridge developed a method to reverse the biological age of human skin cells by 30 years — without erasing their identity as skin cells. The treated cells produced significantly more collagen and healed wounds faster than untreated aged cells. The mechanism is epigenetic: they reset chemical tags on DNA that accumulate with age, resetting gene expression patterns toward a younger state. This is early-stage laboratory research with no human clinical application yet. But what it reveals about how skin ages — and what drives the visible changes — is directly relevant to skin care right now.

The research made headlines in 2022 and continues to resurface — most recently in a widely shared Instagram post — because the finding is genuinely significant. Researchers at the Babraham Institute developed a method to 'time jump' human skin cells by 30 years, turning back the ageing clock for cells without losing their specialised function.

Before explaining what this means for skin care, one important clarification: as of late 2025, no completed peer-reviewed human clinical trial has demonstrated Yamanaka factor age reversal in people. Claims that clinical trials for skin rejuvenation treatments would arrive by late 2025 have not materialised in the peer-reviewed literature. This is promising early science — not an available treatment. The reason it matters for a skin care audience is what it reveals about the mechanism of skin aging, not what it offers as an immediate therapy.

What did the Babraham Institute researchers actually do?

The study built on the Nobel Prize-winning work of Shinya Yamanaka, who discovered that four specific proteins — now called Yamanaka factors — could reprogram adult cells back into embryonic stem cells. The problem with full reprogramming is that it erases the cell's identity entirely: a skin cell becomes an embryo-like cell that has lost all its specialised function.

The Babraham team's innovation was transient reprogramming — applying Yamanaka factors for just 13 days using a doxycycline-inducible genetic cassette, then withdrawing them before cells lost their identity. The result was cells that remained skin cells, yet exhibited younger molecular and epigenetic behaviour.

By two measures of cellular age — the epigenetic clock (chemical tags present throughout the genome that indicate age) and the transcriptome (all gene readouts produced by the cell) — the reprogrammed cells matched the profile of cells that were 30 years younger compared to reference datasets.

The practical outcomes: treated cells showed 300% increased collagen production and faster wound healing, suggesting potential for understanding biological aging mechanisms. These are not cosmetic outcomes — collagen production and wound healing speed are functional measures of how young a skin cell is behaving.

What is the epigenetic clock — and why does it matter for skin?

The epigenetic clock is one of the most important concepts to understand for anyone interested in how skin actually ages. It refers to a specific pattern of chemical modifications — primarily DNA methylation marks — that accumulate on the genome in a highly predictable pattern as we age. These marks don't change the DNA sequence itself, but they change which genes are turned on or off, and they change in a pattern so consistent across individuals that researchers can estimate biological age from them more accurately than from calendar age alone.

Epigenetic changes drive skin aging by reprogramming gene activity without altering the DNA sequence. These modifications act as molecular switches, silencing regenerative pathways while activating inflammatory and senescent programs.

In practical terms for skin: as the epigenetic clock advances, fibroblasts (the cells that produce collagen and elastin) progressively reduce their output. Keratinocytes (the cells that form the skin barrier) become less efficient at replication. The skin's ability to heal and self-renew slows. The visible signs of aging — loss of firmness, thinning, reduced luminosity, slower wound healing — are the surface expression of these epigenetic shifts happening at the cellular level.

What accelerates the epigenetic clock in skin — and what slows it?

The Babraham research reveals the mechanism of skin aging. The subsequent research on epigenetic clocks tells us what accelerates and slows that mechanism — which is where skin care becomes directly relevant.

Environmental and lifestyle factors — particularly ultraviolet radiation, pollution, smoking, diet, and stress — accelerate skin aging through epigenetic mechanisms. These are not simply damaging the skin surface — they are advancing the epigenetic clock, triggering the same methylation pattern changes the Babraham researchers reversed in the lab.

What does this mean for the ingredients in a botanical face serum?

The Babraham research is not an argument for any skincare product. It is a revelation of mechanism — skin aging is primarily epigenetic, driven by accumulated changes in gene expression rather than irreversible structural damage. This matters because it means the skin's regenerative capacity is not simply gone with age. It is suppressed by a pattern of epigenetic marks that, at least in principle, can be modulated.

The botanical actives in the Laritelle Rejuvenating Face Serum — helichrysum, frankincense, melissa, geranium, lavender — are not epigenetic reprogramming agents. They cannot reset 30 years of methylation marks in 13 days as the Babraham experiment did. What they can do is address the upstream drivers that advance the epigenetic clock:

Frequently Asked Questions

Can you reverse skin aging with epigenetic reprogramming?

In laboratory conditions, yes — the Babraham Institute demonstrated 30-year reversal of epigenetic age markers in cultured skin cells, with 300% increased collagen production. In humans, no — as of 2026, no completed peer-reviewed clinical trial has demonstrated safe epigenetic reprogramming in living people. The research is a proof of concept, not an available treatment.

What is the epigenetic clock in skin?

A pattern of chemical modifications (primarily DNA methylation marks) that accumulate on the genome in a predictable pattern as skin cells age. These marks don't change the DNA sequence but change which genes are active — progressively silencing collagen production, barrier repair, and cell renewal pathways while activating inflammatory and senescent programs. The epigenetic clock can be measured to estimate biological (vs chronological) skin age.

What accelerates skin aging at the cellular level?

UV radiation is the most potent accelerator of skin epigenetic aging. Chronic inflammation, oxidative stress from pollution and smoking, and inadequate antioxidant protection all advance the epigenetic clock. These factors drive the same methylation pattern changes the Babraham researchers reversed in the lab — which is why UV protection and antioxidant care directly address the mechanism of skin aging, not just its surface appearance.

What does collagen loss actually mean at the cellular level?

As fibroblasts accumulate epigenetic aging marks, they progressively reduce collagen and elastin production and enter a state called senescence — where they stop regenerating and begin releasing inflammatory signals that accelerate aging in surrounding cells. The Babraham reprogrammed cells' 300% collagen increase reflects a restoration of what young fibroblasts naturally do before senescence suppresses that function.

What can I do now based on this research?

Three things with direct mechanistic relevance: consistent daily broad-spectrum SPF (the single most evidence-based intervention for slowing UV-driven epigenetic clock advancement), daily antioxidant skin care that reduces the oxidative stress that triggers methylation changes, and anti-inflammatory topical care that reduces the chronic inflammation that accelerates fibroblast senescence. These address the upstream drivers of epigenetic skin aging — not the marks already accumulated, but the rate at which new ones form.